Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study

Overview of attention for article published in JCO Precision Oncology, February 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 27 X users

reddit: 1 Redditor

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 30 X posts from 27 X users, with an upper bound of 170,800 followers.

Oncologist Dr. Anu Gaba co-authored an article in JCO Precision Oncology reporting Targeted Agent and Profiling Utilization Registry Study results for sunitinib treatment in patients with metastatic breast cancer with FGFR1 and FGFR2 alterations. https://…

RT @JCOPO_ASCO: .@OmidHamidMD et al. reporting on @ASCO #TAPUR study where sunitinib did not demonstrate antitumor activity in patients wit…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 26 additional X posts.